Contemporary Pediatrics week in review: Updated COVID-19 vaccines, pediatric diabetes guidelines, and more
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
Contemporary Pediatrics week in review: Updated COVID-19 vaccines, pediatric diabetes guidelines, and more | Image Credit: Contemporary Pediatrics
Thank you for visiting the Contemporary Pediatrics® website. Take a look at some of our top stories from last week (Monday, September 11 to Friday, September 15, 2023) and click each link to read and watch anything you may have missed.
1.) FDA approves, authorizes updated monovalent COVID-19 vaccines
The FDA has approved and authorized for emergency use updated COVID-19 vaccines that are formulated to more effectively target the currently circulating COVID-19 variants.
Click here for the full article.
2.) ADA updates pediatric diabetes guidelines
The 2023 guideline for managing diabetes in children and adolescents highlights risk factors and treatment for type 1 and type 2 diabetes.
Click here for the full article.
3.) FDA accepts sBLA for ALTUVIIIO in children with hemophilia A
A supplemental biologics license application for ALTUVIIIO (Antihemophilic factor; Sanofi) has been accepted by the FDA for use in patients aged 12 years and younger with severe hemophilia A.
Click here for the full article.
4.) Moderna's vaccine shows robust response against 4 influenza strains
Besides its influenza pipeline, mRNA technology is helping this pharmaceutical company create a number of new vaccines for cancer, rare diseases, and infectious diseases.
Click here for the full article.
5.) The current state of transgender reproductive care in the United States
In this interview originally conducted by our sister publication Contemporary OB/GYN, Marci Bowers, MD, shares the biggest takeaways from her presentation on transgender reproductive care, presented at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting in Chicago, Illinois.
